These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19364880)

  • 1. In vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes.
    Lachmann HJ; Lowe P; Felix SD; Rordorf C; Leslie K; Madhoo S; Wittkowski H; Bek S; Hartmann N; Bosset S; Hawkins PN; Jung T
    J Exp Med; 2009 May; 206(5):1029-36. PubMed ID: 19364880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of canakinumab in the cryopyrin-associated periodic syndrome.
    Lachmann HJ; Kone-Paut I; Kuemmerle-Deschner JB; Leslie KS; Hachulla E; Quartier P; Gitton X; Widmer A; Patel N; Hawkins PN;
    N Engl J Med; 2009 Jun; 360(23):2416-25. PubMed ID: 19494217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-1beta and the autoinflammatory diseases.
    Dinarello CA
    N Engl J Med; 2009 Jun; 360(23):2467-70. PubMed ID: 19494224
    [No Abstract]   [Full Text] [Related]  

  • 4. Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria.
    Nakamura Y; Kambe N; Saito M; Nishikomori R; Kim YG; Murakami M; Núñez G; Matsue H
    J Exp Med; 2009 May; 206(5):1037-46. PubMed ID: 19364881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased NLRP3-dependent interleukin 1β secretion in patients with familial Mediterranean fever: correlation with MEFV genotype.
    Omenetti A; Carta S; Delfino L; Martini A; Gattorno M; Rubartelli A
    Ann Rheum Dis; 2014 Feb; 73(2):462-9. PubMed ID: 23505242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome.
    Koné-Paut I; Galeotti C
    Expert Rev Clin Immunol; 2015; 11(10):1083-92. PubMed ID: 26312542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canakinumab for the treatment of cryopyrin-associated periodic syndromes.
    Walsh GM
    Drugs Today (Barc); 2009 Oct; 45(10):731-5. PubMed ID: 20069137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS).
    Kuemmerle-Deschner JB; Ramos E; Blank N; Roesler J; Felix SD; Jung T; Stricker K; Chakraborty A; Tannenbaum S; Wright AM; Rordorf C
    Arthritis Res Ther; 2011 Feb; 13(1):R34. PubMed ID: 21356079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unified Modeling of Familial Mediterranean Fever and Cryopyrin Associated Periodic Syndromes.
    Bozkurt Y; Demir A; Erman B; Gül A
    Comput Math Methods Med; 2015; 2015():893507. PubMed ID: 26161132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRP8 and MRP14, phagocyte-specific danger signals, are sensitive biomarkers of disease activity in cryopyrin-associated periodic syndromes.
    Wittkowski H; Kuemmerle-Deschner JB; Austermann J; Holzinger D; Goldbach-Mansky R; Gramlich K; Lohse P; Jung T; Roth J; Benseler SM; Foell D
    Ann Rheum Dis; 2011 Dec; 70(12):2075-2081. PubMed ID: 21908452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of canakinumab in cryopyrin-associated periodic syndromes: results from a Spanish cohort.
    Anton J; Calvo I; Fernández-Martin J; Gamir ML; Merino R; Jimenez-Treviño S; Sevilla B; Cabades F; Bou R; Arostegui JI
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S67-71. PubMed ID: 26243511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment options for cryopyrin-associated periodic syndromes.
    Landmann EC; Walker UA
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):855-864. PubMed ID: 28586272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting IL-1beta in disease; the expanding role of NLRP3 inflammasome.
    Mitroulis I; Skendros P; Ritis K
    Eur J Intern Med; 2010 Jun; 21(3):157-63. PubMed ID: 20493414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies.
    Hoffman HM; Throne ML; Amar NJ; Sebai M; Kivitz AJ; Kavanaugh A; Weinstein SP; Belomestnov P; Yancopoulos GD; Stahl N; Mellis SJ
    Arthritis Rheum; 2008 Aug; 58(8):2443-52. PubMed ID: 18668535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases.
    Bettiol A; Lopalco G; Emmi G; Cantarini L; Urban ML; Vitale A; Denora N; Lopalco A; Cutrignelli A; Lopedota A; Venerito V; Fornaro M; Vannacci A; Rigante D; Cimaz R; Iannone F
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30999610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inflammasome, autoinflammatory diseases, and gout.
    Pétrilli V; Martinon F
    Joint Bone Spine; 2007 Dec; 74(6):571-6. PubMed ID: 17714972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic properties of canakinumab, a human anti-interleukin-1β monoclonal antibody.
    Chakraborty A; Tannenbaum S; Rordorf C; Lowe PJ; Floch D; Gram H; Roy S
    Clin Pharmacokinet; 2012 Jun; 51(6):e1-18. PubMed ID: 22550964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canakinumab for the treatment of familial Mediterranean fever.
    Ozdogan H; Ugurlu S
    Expert Rev Clin Immunol; 2017 May; 13(5):393-404. PubMed ID: 28362189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canakinumab: a human anti-IL-1β monoclonal antibody for the treatment of cryopyrin-associated periodic syndromes.
    Church LD; McDermott MF
    Expert Rev Clin Immunol; 2010 Nov; 6(6):831-41. PubMed ID: 20979548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating inflammation by blocking interleukin-1 in humans.
    Dinarello CA; van der Meer JW
    Semin Immunol; 2013 Dec; 25(6):469-84. PubMed ID: 24275598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.